Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals在其用於阿爾茨海默病篩查藥物Sabirnetug的臨床試驗第2階段展示出令人鼓舞的結果
Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug
Acumen Pharmaceuticals在其用於阿爾茨海默病篩查藥物Sabirnetug的臨床試驗第2階段展示出令人鼓舞的結果
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間